These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Securinine Derivatives as Potential Anti-amyloid Therapeutic Approach.
    Author: Neganova ME, Klochkov SG, Petrova LN, Shevtsova EF, Afanasieva SV, Chudinova ES, Fisenko VP, Bachurin SO, Barreto GE, Aliev G.
    Journal: CNS Neurol Disord Drug Targets; 2017; 16(3):351-355. PubMed ID: 27823572.
    Abstract:
    BACKGROUND: Oxidative stress and amyloid deposition are tightly interconnected pathological features of Alzheimer disease. In this respect, both amyloid production and aggregation may be stimulated by oxidative stress and also the increase of pathogenic β-amyloid and its aggregated form lead to oxidative stress progression. Therefore, the search for potential drugs with both antioxidant and antiaggregation properties are of great interest. METHODS: In this study, we described the stereospecific synthesis of alkaloid securinine aminoderivatives. RESULTS: We showed that the newly synthesized compounds possess antioxidant and metal-chelating properties. Indeed, we report that one compound has inhibitory effects towards μ-amyloid aggregation. CONCLUSION: Based on these results, aminoderivatives of securinine scaffold are promising compounds for development of new drugs for the treatment of neurodegenerative diseases.
    [Abstract] [Full Text] [Related] [New Search]